These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 16401540
41. Outcomes associated with bilateral internal thoracic artery grafting: the importance of age. Kieser TM, Lewin AM, Graham MM, Martin BJ, Galbraith PD, Rabi DM, Norris CM, Faris PD, Knudtson ML, Ghali WA, APPROACH Investigators. Ann Thorac Surg; 2011 Oct; 92(4):1269-75; discussion 1275-6. PubMed ID: 21958771 [Abstract] [Full Text] [Related]
43. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Valgimigli M, Malagutti P, Rodriguez Granillo GA, Tsuchida K, Garcia-Garcia HM, van Mieghem CA, Van der Giessen WJ, De Feyter P, de Jaegere P, Van Domburg RT, Serruys PW. Am Heart J; 2006 Nov; 152(5):896-902. PubMed ID: 17070153 [Abstract] [Full Text] [Related]
44. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry. Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE. Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):874-80. PubMed ID: 19180665 [Abstract] [Full Text] [Related]
48. Percutaneous coronary intervention with stenting of left main coronary artery with drug-eluting stent in the setting of acute ST elevation myocardial infarction. Tan CH, Hong MK, Lee CW, Kim YH, Lee CH, Park SW, Park SJ. Int J Cardiol; 2008 May 23; 126(2):224-8. PubMed ID: 17493695 [Abstract] [Full Text] [Related]
49. Revascularization of left anterior descending coronary artery in patients with single and multivessel disease: comparison between off-pump internal thoracic artery and drug-eluting stent. Moshkovitz Y, Mohr R, Braunstein R, Zivi E, Uretzky G, Ben-Gal Y, Herz I. Chest; 2005 Aug 23; 128(2):804-9. PubMed ID: 16100171 [Abstract] [Full Text] [Related]
54. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, Snead D, Mauri L, Cutlip DE, Sousa E. J Am Coll Cardiol; 2007 Oct 02; 50(14):1299-304. PubMed ID: 17903626 [Abstract] [Full Text] [Related]
58. Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary interventions (the IMPRESS-LD study). Ferrero V, Ribichini F, Rognoni A, Marino P, Brunelleschi S, Vassanelli C. Am J Cardiol; 2007 Apr 15; 99(8):1082-6. PubMed ID: 17437731 [Abstract] [Full Text] [Related]
60. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients. Han YL, Wang SL, Jin QM, Liu HW, Ma YY, Wang ZL, Wang DM, Luan B, Wang G. Chin Med J (Engl); 2006 Apr 05; 119(7):544-50. PubMed ID: 16620694 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]